Guru Alan Fournier (Trades, Portfolio) has been investing for more than a quarter of a century. Today he manages Pennant Master Fund, Pennant Windward Master Fund, Broadway Gate Master Fund, Ltd., and Pennant General Partner, LLC. Perhaps understandably, his personal investments have been modest compared to many of the gurus we follow, but in the first quarter of 2015, they were significant, as they usually are.
Gilead Sciences Inc (NASDAQ:GILD), a California-based biotechnology company, is widely considered one of the hottest stocks in the market these days, but Fournier sold his 2,141,000-share stake in the first quarter. Fournier received $101.54 per share. The sale had a -3.8% impact on his portfolio. Continue Reading »